Health Minister J P Nadda said there will be a provision in the rules to provide justification for denying treatment to the patients.

In 2017, the company will finalise construction and validation of the manufacturing plant together with Cipla and products will be commerci...

The plea filed by advocate Parmanand Katara sought directions from the court to avoid any harassment and untouchability of HIV positiv pati...

"As per India HIV estimation 2015 report, an estimated 21.17 lakh people are living with HIV", Health Minister J P Nadda said.

According to IAPAC guidelines 2015, an estimated 50 per cent of people living with HIV globally are unaware of their status.

Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.

Suniti Solomon and her colleagues documented the first evidence of the HIV infection in India in 1986 when blood samples of six commercial ...

The centre, owned by the Municipal Corporation of Greater Mumbai (MCGM), has been built by L&T, which will also operate it.

In the WHO South-East Asia region, as of 2013, there were around 3.4 million people living with HIV and 1.1 million of them are currently o...

The NHRC, vide a reminder on October 28 has given four weeks' time to the Ministry, through its Secretary, to submit the report, the statem...

Govt's objective was to reduce new infections further by 50% and provide comprehensive care and support to all persons living with HIV and ...

MSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.

Shilpa Medicare inked an agreement with Gilead Sciences to increase access to medicines used for treatment of HIV/AIDS.

Drug major Cipla today said it has launched 'Qvir', a four-drug kit priced at Rs 158 per kit to be used for treating HIV/AIDS.

Gilead Sciences has signed deals with 3 Indian firms to collaborate on promoting access to HIV medicine emtricitabine in developing nations.

Patient advocacy and civil society groups working in the area of HIV/AIDS have criticized free trade agreements (FTAs) being signed between...

Generic anti-retroviral drugs manufactured by Indian cos have brought down the cost of first line treatment for HIV patients from $800 to $...